Skip to main content
Erschienen in: Documenta Ophthalmologica 3/2009

01.06.2009 | Case report

Diagnosis in a patient with fundus albipunctatus and atypical fundus changes

verfasst von: Manal Hajali, Gerald A. Fishman, Thaddeus P. Dryja, Meredith O. Sweeney, Martin Lindeman

Erschienen in: Documenta Ophthalmologica | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

We report a case of an 11-year old Caucasian female with nyctalopia since early childhood with an atypical clinical presentation of fundus albipunctatus (FA), and a novel mutation in the RDH5 gene. In addition to white spots in the fundus, patchy areas of hypopigmentation were noted, which were reminiscent for an early stage of retinitis punctata albescens (RPA). Electroretinographic testing (ERG) showed a non-detectable, dark adapted, isolated rod response and a markedly decreased combined rod and cone response to an achromatic stimulus. After patching one eye overnight, both the isolated rod response and combined rod and cone scotopic white flash response were normal. A Goldmann-Weekers dark adapted final threshold response was also within the normal range. The patient showed a previously reported heterozygous mutation for Gly238Trp, and a novel Arg157Gln mutation. Genetic testing and extended ERG and psychophysical testing may be necessary to diagnose FA from early stages of progressive RPA.
Literatur
1.
Zurück zum Zitat Yamamoto H, Simon A, Eriksson U et al (1999) Mutations in the gene encoding 11-cis-retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus. Nat Genet 22(2):188–191. doi:10.1038/9707 PubMedCrossRef Yamamoto H, Simon A, Eriksson U et al (1999) Mutations in the gene encoding 11-cis-retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus. Nat Genet 22(2):188–191. doi:10.​1038/​9707 PubMedCrossRef
2.
Zurück zum Zitat Gonzalez-Fernandez F, Kurz D, Bao Y et al (1999) 11-cis Retinol dehydrogenase mutations as a major cause of the congenital night-blindness disorder known as fundus albipunctatus. Mol Vis 5:41–45PubMed Gonzalez-Fernandez F, Kurz D, Bao Y et al (1999) 11-cis Retinol dehydrogenase mutations as a major cause of the congenital night-blindness disorder known as fundus albipunctatus. Mol Vis 5:41–45PubMed
5.
Zurück zum Zitat Carr RE (1974) Congenital stationary night blindness. Trans Am Ophthalmol Soc 72:448–487PubMed Carr RE (1974) Congenital stationary night blindness. Trans Am Ophthalmol Soc 72:448–487PubMed
6.
7.
Zurück zum Zitat Nakamura M, Skalet J, Miyake Y (2003) RDH5 gene mutations and electroretinogram in fundus albipunctatus with or without macular dystrophy: RDH5 mutations and ERG in fundus albipunctatus. Doc Ophthalmol 107(1):3–11. doi:10.1023/A:1024498826904 PubMedCrossRef Nakamura M, Skalet J, Miyake Y (2003) RDH5 gene mutations and electroretinogram in fundus albipunctatus with or without macular dystrophy: RDH5 mutations and ERG in fundus albipunctatus. Doc Ophthalmol 107(1):3–11. doi:10.​1023/​A:​1024498826904 PubMedCrossRef
9.
10.
Zurück zum Zitat Demirci FY, Rigatti BW, Mah TS, Gorin MB (2004) A novel compound heterozygous mutation in the cellular retinaldehyde-binding protein gene (RLBP1) in a patient with retinitis punctata albescens. Am J Ophthalmol 138(1):171–173. doi:10.1016/j.ajo.2004.02.060 PubMedCrossRef Demirci FY, Rigatti BW, Mah TS, Gorin MB (2004) A novel compound heterozygous mutation in the cellular retinaldehyde-binding protein gene (RLBP1) in a patient with retinitis punctata albescens. Am J Ophthalmol 138(1):171–173. doi:10.​1016/​j.​ajo.​2004.​02.​060 PubMedCrossRef
11.
Zurück zum Zitat Fishman GA, Roberts MF, Derlacki DJ et al (2004) Novel mutations in the cellular retinaldehyde-binding protein gene (RLBP1) associated with retinitis punctata albescens: evidence of inter-familial genetic heterogeneity and fundus changes in heterozygotes. Arch Ophthalmol 122(1):70–75. doi:10.1001/archopht.122.1.70 PubMedCrossRef Fishman GA, Roberts MF, Derlacki DJ et al (2004) Novel mutations in the cellular retinaldehyde-binding protein gene (RLBP1) associated with retinitis punctata albescens: evidence of inter-familial genetic heterogeneity and fundus changes in heterozygotes. Arch Ophthalmol 122(1):70–75. doi:10.​1001/​archopht.​122.​1.​70 PubMedCrossRef
13.
Zurück zum Zitat Morimura H, Berson EL, Dryja TP (1999) Recessive mutations in the RLBP1 gene encoding cellular retinaldehyde-binding protein in a form of retinitis punctata albescens. Invest Ophthalmol Vis Sci 40(5):1000–1004PubMed Morimura H, Berson EL, Dryja TP (1999) Recessive mutations in the RLBP1 gene encoding cellular retinaldehyde-binding protein in a form of retinitis punctata albescens. Invest Ophthalmol Vis Sci 40(5):1000–1004PubMed
14.
Zurück zum Zitat Burstedt M, Sandgren O, Holmegren G, Forsman-Semb K (1999) Bothnia dystrophy caused by mutations in the cellular retinaldehyde-binding protein gene (RLBP1) on chromosome 15q26. Invest Ophthalmol Vis Sci 40(5):995–1000PubMed Burstedt M, Sandgren O, Holmegren G, Forsman-Semb K (1999) Bothnia dystrophy caused by mutations in the cellular retinaldehyde-binding protein gene (RLBP1) on chromosome 15q26. Invest Ophthalmol Vis Sci 40(5):995–1000PubMed
15.
Zurück zum Zitat Maw MA, Kennedy B, Knight A et al (1997) Mutation of the gene encoding cellular retinaldehyde-binding protein in autosomal recessive retinitis pigmentosa. Nat Genet 17(2):198–200. doi:10.1038/ng1097-198 PubMedCrossRef Maw MA, Kennedy B, Knight A et al (1997) Mutation of the gene encoding cellular retinaldehyde-binding protein in autosomal recessive retinitis pigmentosa. Nat Genet 17(2):198–200. doi:10.​1038/​ng1097-198 PubMedCrossRef
16.
Zurück zum Zitat Kajiwara K, Sandberg MA, Berson EL, Dryja TP (1993) A null mutation in the human peripherin/RDS gene in a family with autosomal dominant retinitis punctata albescens. Nat Genet 3(3):208–212. doi:10.1038/ng0393-208 PubMedCrossRef Kajiwara K, Sandberg MA, Berson EL, Dryja TP (1993) A null mutation in the human peripherin/RDS gene in a family with autosomal dominant retinitis punctata albescens. Nat Genet 3(3):208–212. doi:10.​1038/​ng0393-208 PubMedCrossRef
17.
Zurück zum Zitat Souied E, Soubrane G, Benlian P, Coscas GJ et al (1996) Retinitis punctata albescens associated with the arg135-to-trp mutation in the rhodopsin gene. Am J Ophthalmol 121(1):19–25PubMed Souied E, Soubrane G, Benlian P, Coscas GJ et al (1996) Retinitis punctata albescens associated with the arg135-to-trp mutation in the rhodopsin gene. Am J Ophthalmol 121(1):19–25PubMed
18.
Zurück zum Zitat Peachey NS, Fishman GA, Derlacki DJ, Alexander KR (1988) Rod and cone dysfunction in carriers of X-linked retinitis pigmentosa. Ophthalmology 95(5):677–685PubMed Peachey NS, Fishman GA, Derlacki DJ, Alexander KR (1988) Rod and cone dysfunction in carriers of X-linked retinitis pigmentosa. Ophthalmology 95(5):677–685PubMed
19.
Zurück zum Zitat Ripps H (1982) Night blindness revisited: from man to molecules. Proctor lecture. Invest Ophthalmol Vis Sci 23(5):588–609PubMed Ripps H (1982) Night blindness revisited: from man to molecules. Proctor lecture. Invest Ophthalmol Vis Sci 23(5):588–609PubMed
21.
Zurück zum Zitat Lidén M, Romert A, Tryggvason K, Persson B, Eriksson U (2001) Biochemical defects in 11-cis-retinol dehydrogenase mutants associated with fundus albipunctatus. J Biol Chem 276(52):49251–49257. doi:10.1074/jbc.M107337200 PubMedCrossRef Lidén M, Romert A, Tryggvason K, Persson B, Eriksson U (2001) Biochemical defects in 11-cis-retinol dehydrogenase mutants associated with fundus albipunctatus. J Biol Chem 276(52):49251–49257. doi:10.​1074/​jbc.​M107337200 PubMedCrossRef
24.
Zurück zum Zitat Nakamura M, Hotta Y, Tanikawa A, Terasaki H, Miyake Y (2000) A high association with cone dystrophy in Fundus albipunctatus caused by mutations of the RDH5 gene. Invest Ophthalmol Vis Sci 41(12):3925–3932PubMed Nakamura M, Hotta Y, Tanikawa A, Terasaki H, Miyake Y (2000) A high association with cone dystrophy in Fundus albipunctatus caused by mutations of the RDH5 gene. Invest Ophthalmol Vis Sci 41(12):3925–3932PubMed
Metadaten
Titel
Diagnosis in a patient with fundus albipunctatus and atypical fundus changes
verfasst von
Manal Hajali
Gerald A. Fishman
Thaddeus P. Dryja
Meredith O. Sweeney
Martin Lindeman
Publikationsdatum
01.06.2009
Verlag
Springer-Verlag
Erschienen in
Documenta Ophthalmologica / Ausgabe 3/2009
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-008-9151-8

Weitere Artikel der Ausgabe 3/2009

Documenta Ophthalmologica 3/2009 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.